Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 6, 2001, Pages 598-612

  Pagenstecher, Axel ^a   Wussler, Eva M ^a   Opdenakker, Ghislain ^c   Volk, Benedikt ^a   Campbell, Iain L ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Matrix metalloproteinase; Primary brain tumors; TIMP

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 16; RIBONUCLEASE; RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; BLEEDING; BLOOD VESSEL WALL; BRAIN TUMOR; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; EPENDYMOMA; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL;

EID: 0035014695     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.6.598     Document Type: Article

References (45)

1. Expression of tissue inhibitors of metalloproteinases: Negative regulators of human glioblastoma invasion in vivo
2. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
3. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors
4. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors
5. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors
6. Expression of matrix metalloproteinases and their inhibitors in human brain tumors
7. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340
8. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro
9. Inhibition of SV 40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice
10. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis
11. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line
12. Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: Modulation of astrocytoma invasive potential
13. Activation mechanisms of matrix metalloproteinases
14. Biology and biochemistry of proteinases in tumor invasion
15. A matrix metalloproteinase expressed on the surface of invasive tumour cells
16. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP)
17. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2)
18. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system
19. Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues
20. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4
21. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
22. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
23. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
24. RNase protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs
25. Simultaneous analysis of multiple cytokine receptor mRNAs by RNase protection assay in LPS-induced endotoxemia
26. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia
27. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity
28. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes
29. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8
30. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
31. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40)
32. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors
33. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2
34. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA
35. White matter microglia produce membrane-type matrix metalloprotease, an activatior of gelatinase A, in human brain tissues
36. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors
37. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter
38. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
39. Proteases and their inhibitors in human brain tumours: A review
40. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
41. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization
42. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (timp-1) for a wide range of cells - A possible new growth factor in serum
43. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
44. TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin